Subscribe to RSS
DOI: 10.1055/a-2756-0510
Patient-Level Value Analysis in Primary Total Knee Arthroplasty: An Analysis of Time-Driven Activity-Based Costs and Symptom Improvement in 2,789 Procedures
Authors
Funding Information None.
Abstract
Value in health care is defined as optimized patient-centered outcomes and streamlined costs of care. A patient-level value analysis (PLVA) is a novel value-based health care research method. In a PLVA, the ratio of outcomes to cost is calculated for each individual patient in a cohort, and factors that optimize value are investigated. We performed a PLVA in primary total knee arthroplasty (TKA). We conducted a retrospective analysis of a prospectively maintained multi-institutional arthroplasty registry. A total of 2,789 primary manual TKAs were analyzed. Knee Osteoarthritis Outcome Score-Physical Function Short-Form (KOOS-PS) scores and costs of care using time-driven activity-based costing (TDABC) were collected. All costs were converted from U.S. dollars to arbitrary cost units (CUs) to protect confidential hospital financial data. The primary outcome was the value quotient (Value KOOS-PS), or the ratio of 1-year improvement in KOOS-PS to the cost of care, which was converted to a scale with a maximum of 100. Multivariable forward linear regression determined factors impacting value in primary TKA. The mean improvement in KOOS-PS was 15.2. The mean cost of care was 859 CUs. The largest contributors to cost were the implant cost (378 CUs, 44.0%) and intraoperative personnel cost (173 CUs, 20.1%). Patient and hospital factors independently correlated with improved TKA Value KOOS-PS included home discharge (adjusted mean difference: +7.8; p < 0.001), outpatient surgery (adjusted mean difference: +3.6; p < 0.001), lower preoperative KOOS-PS score (adjusted mean difference: +0.6; p < 0.001), lower Charlson Comorbidity Index (adjusted mean difference: +0.6; p = 0.006), and lower body mass index (BMI; adjusted mean difference: +0.2; p = 0.001). Using TDABC and patient-reported outcome measures, we performed a PLVA. We found that the largest contributor to the cost of care was the implant cost. The highest value TKAs occurred in an outpatient setting with home discharges, for patients with more severe preoperative knee symptoms, fewer comorbidities, and lower BMI. Surgeons and hospital administrators can use these findings to inform strategies to optimize value in TKA.
Note
This investigation was performed at the Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Publication History
Received: 17 March 2025
Accepted: 25 November 2025
Accepted Manuscript online:
27 November 2025
Article published online:
17 December 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Schwartz AJ, Bozic KJ, Etzioni DA. Value-based total hip and knee arthroplasty: A framework for understanding the literature. J Am Acad Orthop Surg 2019; 27 (01) 1-11 . Accessed November 28, 2025 at: https://journals.lww.com/jaaos/Fulltext/2019/01010/Value_based_Total_Hip_and_Knee_Arthroplasty__a.1.aspx
- 2 Porter ME. What is value in health care?. N Engl J Med 2010; 363 (26) 2477-2481
- 3 Hill BG, Shah S, Moschetti WE, Schilling PL. Do patient-reported outcomes reflect objective measures of function? Implications for total knee arthroplasty. J Arthroplasty 2023; 38 (7 Suppl 2): S162-S168.e3
- 4 Squitieri L, Bozic KJ, Pusic AL. The role of patient-reported outcome measures in value-based payment reform. Value Health 2017; 20 (06) 834-836
- 5 Hung A, Li Y, Keefe FJ. et al. Ninety-day and one-year healthcare utilization and costs after knee arthroplasty. Osteoarthritis Cartilage 2019; 27 (10) 1462-1469
- 6 Mont MA, Cool C, Gregory D, Coppolecchia A, Sodhi N, Jacofsky DJ. Health care utilization and payer cost analysis of robotic arm assisted total knee arthroplasty at 30, 60, and 90 days. J Knee Surg 2021; 34 (03) 328-337
- 7 Akhavan S, Ward L, Bozic KJ. Time-driven activity-based costing more accurately reflects costs in arthroplasty surgery. Clin Orthop Relat Res 2016; 474 (01) 8-15 . Accessed November 28, 2025 at: https://journals.lww.com/clinorthop/fulltext/2016/01000/time_driven_activity_based_costing_more_accurately.3.aspx
- 8 Jayakumar P, Triana B, Bozic KJ. Editorial Commentary: The value of time-driven, activity-based costing in health care delivery. Arthroscopy 2021; 37 (05) 1628-1631
- 9 Lim PL, Goh GS, Bedair HS, Melnic CM. Weighing the impact: The influence of body mass index on facility costs in total joint arthroplasty. J Arthroplasty 2024; 39 (12) 2904-2910
- 10 Kaplan RS, Porter ME. How to solve the cost crisis in health care. Harv Bus Rev 2011; 89 (09) 46-52 , 54, 56–61 passim
- 11 Porter ME, Lee TH. The strategy that will fix health care. Harv Bus Rev 2013; 91 (10) 50-70
- 12 Kaplan RS, Anderson SR. Time-driven activity-based costing. Harv Bus Rev 2004; 82 (11) 131-138 , 150
- 13 Wise KL, Parikh HR, Okelana B. et al. Measurement of value in rotator cuff repair: patient-level value analysis for the 1-year episode of care. J Shoulder Elbow Surg 2022; 31 (01) 72-80
- 14 Doxey SA, Huyke-Hernández FA, Davidson S. et al. Patient-level value analysis in total hip arthroplasty: Optimizing the value of care delivery. J Bone Joint Surg 2024; 106: 2338-2346 . Accessed November 28, 2025 at: https://journals.lww.com/jbjsjournal/fulltext/9900/patient_level_value_analysis_in_total_hip.1235.aspx
- 15 Davis AM, Perruccio AV, Canizares M. et al. Comparative, validity and responsiveness of the HOOS-PS and KOOS-PS to the WOMAC physical function subscale in total joint replacement for osteoarthritis. Osteoarthritis Cartilage 2009; 17 (07) 843-847
- 16 Kimball CC, Nichols CI, Nunley RM, Vose JG, Stambough JB. Skilled nursing facility star rating, patient outcomes, and readmission risk after total joint arthroplasty. J Arthroplasty 2018; 33 (10) 3130-3137
- 17 Albright P, Only A, Parikh HR. et al. External fixation characteristics drive cost of care for high-energy tibial plateau fractures. J Orthop Trauma 2022; 36 (04) 189-194
- 18 Porter ME. What is value in health care?. N Engl J Med 2010; 363 (26) 2477-2481
- 19 Menendez ME, Mahendraraj KA, Grubhofer F, Muniz AR, Warner JJP, Jawa A. Variation in the value of total shoulder arthroplasty. J Shoulder Elbow Surg 2021; 30 (08) 1924-1930
- 20 Kalainov DM. Value-based healthcare: Controlling costs through a value analysis committee. Clin Orthop Relat Res 2024; 482 (05) 769-771 . Accessed November 28, 2025 at: https://journals.lww.com/clinorthop/fulltext/2024/05000/value_based_healthcare__controlling_costs_through.5.aspx
- 21 Sambare TD, Bozic KJ. Preparing for an era of episode-based care in total joint arthroplasty. J Arthroplasty 2021; 36 (03) 810-815
- 22 Spiering TJ, Firth AD, Mousoulis C, Hallstrom BR, Gagnier JJ. Establishing the minimally important difference for the KOOS-Joint Replacement and PROMIS Global-10 in patients after total knee arthroplasty. Orthop J Sports Med 2024;12(2):23259671231218260
- 23 Katakam A, Bragdon CR, Chen AF, Melnic CM, Bedair HS. Elevated body mass index is a risk factor for failure to achieve the Knee Disability and Osteoarthritis Outcome Score-Physical Function Short Form minimal clinically important difference following total knee arthroplasty. J Arthroplasty 2021; 36 (05) 1626-1632
- 24 Goh GS, Baker CM, Tarabichi S, Clark SC, Austin MS, Lonner JH. The paradox of patient-reported outcome measures: Should we prioritize “feeling better” or “feeling good” after total knee arthroplasty?. J Arthroplasty 2022; 37 (09) 1751-1758
- 25 Connelly JW, Galea VP, Rojanasopondist P. et al. Which preoperative factors are associated with not attaining acceptable levels of pain and function after TKA? Findings from an international multicenter study. Clin Orthop Relat Res 2020; 478 (05) 1019-1028 . Accessed November 28, 2025 at: https://journals.lww.com/clinorthop/fulltext/2020/05000/which_preoperative_factors_are_associated_with_not.17.aspx
- 26 Dlott CC, Moore A, Nelson C. et al. Preoperative risk factor optimization lowers hospital length of stay and postoperative emergency department visits in primary total hip and knee arthroplasty patients. J Arthroplasty 2020; 35 (06) 1508-1515.e2
- 27 Olsen AS, Giunta NM, Jamison MP, Chen AF, Fitz W, Iorio R. A total knee arthroplasty preoperative optimization program managed by an advanced practice provider (physician assistant) decreases complications and cost: A pilot study. J Arthroplasty 2023; 38 (6S): S77-S80
- 28 Botros M, Guirguis P, Balkissoon R, Myers TG, Thirukumaran CP, Ricciardi BF. Is morbid obesity a modifiable risk factor in patients who have severe knee osteoarthritis and do not have a formal perioperative optimization program?. J Arthroplasty 2024; 39 (03) 658-664
- 29 Singh JA, Lewallen DG. Medical and psychological comorbidity predicts poor pain outcomes after total knee arthroplasty. Rheumatology (Oxford) 2013; 52 (05) 916-923
- 30 Kotzur TM, Singh A, Peng LN, Makhani AA, Seifi A, Moore CC. Comparing common risk assessment tools to predict outcomes in total knee arthroplasty. J Arthroplasty 2024; 39 (9S2): S163 , 170.e11
- 31 Giori NJ, Amanatullah DF, Gupta S, Bowe T, Harris AHS. Risk reduction compared with access to care: Quantifying the trade-off of enforcing a body mass index eligibility criterion for joint replacement. J Bone Joint Surg Am 2018; 100 (07) 539-545
- 32 Price AJ, Alvand A, Troelsen A. et al. Knee replacement. Lancet 2018; 392 (10158): 1672-1682
- 33 London DA, Vilensky S, O'Rourke C, Schill M, Woicehovich L, Froimson MI. Discharge disposition after joint replacement and the potential for cost savings: Effect of hospital policies and surgeons. J Arthroplasty 2016; 31 (04) 743-748
- 34 Gibon E, Parvataneni HK, Prieto HA, Photos LL, Stone WZ, Gray CF. Outpatient total knee arthroplasty: Is it economically feasible in the hospital setting?. Arthroplast Today 2020; 6 (02) 231-235
- 35 Katzman JL, Thomas J, Ashkenazi I, Lajam CM, Rozell JC, Schwarzkopf R. The financial burden of patient comorbidities on total knee arthroplasty procedures: A matched cohort analysis of patients who have a high and non-high comorbidity burden. J Arthroplasty 2025; 40 (07) 1672-1678
- 36 Newhouse JP. Accounting for teaching hospitals' higher costs and what to do about them. Health Aff (Millwood) 2003; 22 (06) 126-129
- 37 Lavernia CJ, Sierra RJ, Hernandez RA. The cost of teaching total knee arthroplasty surgery to orthopaedic surgery residents. Clin Orthop Relat Res 2000; (380) 99-107 . Accessed November 28, 2025 at: https://journals.lww.com/clinorthop/fulltext/2000/11000/the_cost_of_teaching_total_knee_arthroplasty.14.aspx
- 38 Palsis JA, Brehmer TS, Pellegrini VD, Drew JM, Sachs BL. The Cost of Joint Replacement. Comparing two approaches to evaluating costs of total hip and knee arthroplasty. J Bone Joint Surg Am 2018; 100 (04) 326-333 . Accessed November 28, 2025 at: https://journals.lww.com/jbjsjournal/fulltext/2018/02210/the_cost_of_joint_replacement__comparing_two.7.aspx
- 39 Bovonratwet P, Shen TS, Ast MP, Mayman DJ, Haas SB, Su EP. Reasons and risk factors for 30-day readmission after outpatient total knee arthroplasty: A review of 3015 cases. J Arthroplasty 2020; 35 (09) 2451-2457
- 40 Mahajan SM, Mahajan AS, Nguyen C, Bui J, Abbott BT, Osborne T. Risk factors for readmissions after total joint replacement: A meta-analysis. JBJS Rev 2021; 9 (06) e20.00122 . Accessed November 28, 2025 at: https://journals.lww.com/jbjsreviews/fulltext/2021/06000/risk_factors_for_readmissions_after_total_joint.6.aspx
- 41 Mahajan SM, Nguyen C, Bui J, Kunde E, Abbott BT, Mahajan AS. Risk factors for readmission after knee arthroplasty based on predictive models: A systematic review. Arthroplast Today 2020; 6 (03) 390-404
- 42 Yayac M, Harrer S, Hozack WJ, Parvizi J, Courtney PM. The use of cementless components does not significantly increase procedural costs in total knee arthroplasty. J Arthroplasty 2020; 35 (02) 407-412
- 43 Gandhi N, Qadeer AS, Meher A. et al. Costs and models used in the economic analysis of total knee replacement (TKR): A systematic review. PLoS ONE 2023; 18 (07) e0280371